• Molecular NameSulfapyridine
  • Synonym2-Sulfanilamidopyridin; 2-Sulfanilamidopyridine; 2-Sulfanilylaminopyridine; 2-Sulfapyridine; 4-(2-Pyridinylsulfonyl)aniline; 4-[(2-Pyridylamino)sulfonyl]aniline; N-2-Pyridylsulfanilamide; N(sup 1)-2-Pyridylsulfanilamide; N(sup1)-Pyridylsulfanilamide; N1-2-Pyridylsulfanilamide; Sulphapyridine
  • Weight249.294
  • Drugbank_IDDB00891
  • ACS_NO000144-83-2
  • Show 3D model
  • LogP (experiment)0.35
  • LogP (predicted, AB/LogP v2.0)0.58
  • pka8.4 (25°)
  • LogD (pH=7, predicted)0.57
  • Solubility (experiment)0.497 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-2.35
  • LogSw (predicted, AB/LogsW2.0)0.31
  • Sw (mg/ml) (predicted, ACD/Labs)1.1
  • No.of HBond Donors3
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds3
  • TPSA93.46
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA sulfonamide antibacterial.
  • Absorption_value70.0
  • Absorption (description)Approximately 60-80%
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding50.0
  • Volume of distribution (VD)0.4 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life6 h in rapid acetylators, increased in slow acetylators to about 13 h.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=15800 mg/Kg
  • LD50 (mouse)N/A